Management of malignant pleural effusions.
Malignant pleural effusion is a common clinical problem. Evacuation of the pleural fluid and prevention of its reaccumulation are the main aims of management. Pleurodesis should be attempted early, although considerable practice variations exist in the way it is performed. There is a lack of consensus among respiratory physicians worldwide on the optimal method and agent for pleurodesis. Talc remains the most commonly used pleurodesing compound in most countries. While talc produces a higher success rate than other compounds, it generates more side-effects. The association between talc and ARDS continues to be debated. Ambulatory small-bore pleural catheter drainage followed by intrapleural instillation of a pleurodesing agent is increasingly accepted as an alternative to conventional in-patient pleurodesis. Development of novel methods to control pleural fluid formation should be made a high priority in future pleural research.
Lee
Y C Gary
YC
The Centre for Respiratory Research, University College London, London, UK. ycgarylee@hotmail.com
Light
Richard W
RW
D006801:Humans; D018579:Patient Selection; D016066:Pleural Effusion, Malignant / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D018700:Pleurodesis; D012008:Recurrence; D013627:Talc / Q000008:administration & dosage
D013627:Talc